Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia

The Antiphospholipid Antibodies in Stroke Study Group

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

We reviewed the clinical and laboratory data of 128 patients with cerebrovascular disease and anti phospholipid antibodies. Cases were evenly divided between men and women, and the mean age of the study group was 46 years. Cerebral infarction occurred in 97 patients, and transient hemispheric ischemic attacks without stroke were recorded in 19; 12 suffered ocular ischemia. Systemic lupus erythematosus was diagnosed in 16% of all cases. Histories of systemic thromboembolic events and recurrent miscarriages were noted in 14% of the patients and in 19% of the women, respectively. Evidence of cerebral infarction preceding the index event was present in 30% of cases. During a mean follow-up of 16 months, nine of 96 (9%) patients sustained new cerebral infarctions. Of 72 echocardiographie studies, 16 (22%) showed valvular abnormalities. Cerebral angiography detected intracranial lesions in 24 of 49 patients (49%). These data indicate that antiphospholipid antibodies can be identified in stroke patients without known autoimmune disorders. They also suggest that antiphospholipid antibody- associated cerebrovascular ischemia may be recurrent and often occurs in patients with systemic thromboembolic events. Our findings should help design a prospective clinical trial that will assess the risk of recurrent thromboembolism in this population, identify stroke risk factors, and address therapy.

Original languageEnglish (US)
Pages (from-to)1268-1273
Number of pages6
JournalStroke
Volume21
Issue number9
DOIs
StatePublished - Jan 1 1990

Fingerprint

Antiphospholipid Antibodies
Brain Ischemia
Cerebral Infarction
Stroke
Ischemia
Cerebrovascular Disorders
Habitual Abortion
Cerebral Angiography
Thromboembolism
Transient Ischemic Attack
Systemic Lupus Erythematosus
Anti-Idiotypic Antibodies
Phospholipids
Age Groups
Clinical Trials
Population

Keywords

  • Anticoagulants, anticardiolipin antibodies
  • Anticoagulants, antiphospholipid antibodies
  • Cerebrovascular disorders

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. / The Antiphospholipid Antibodies in Stroke Study Group.

In: Stroke, Vol. 21, No. 9, 01.01.1990, p. 1268-1273.

Research output: Contribution to journalArticle

The Antiphospholipid Antibodies in Stroke Study Group 1990, 'Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia', Stroke, vol. 21, no. 9, pp. 1268-1273. https://doi.org/10.1161/01.STR.21.9.1268
The Antiphospholipid Antibodies in Stroke Study Group. / Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. In: Stroke. 1990 ; Vol. 21, No. 9. pp. 1268-1273.
@article{8b0d64f2eab94c50b33390a7cc9ac04f,
title = "Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia",
abstract = "We reviewed the clinical and laboratory data of 128 patients with cerebrovascular disease and anti phospholipid antibodies. Cases were evenly divided between men and women, and the mean age of the study group was 46 years. Cerebral infarction occurred in 97 patients, and transient hemispheric ischemic attacks without stroke were recorded in 19; 12 suffered ocular ischemia. Systemic lupus erythematosus was diagnosed in 16{\%} of all cases. Histories of systemic thromboembolic events and recurrent miscarriages were noted in 14{\%} of the patients and in 19{\%} of the women, respectively. Evidence of cerebral infarction preceding the index event was present in 30{\%} of cases. During a mean follow-up of 16 months, nine of 96 (9{\%}) patients sustained new cerebral infarctions. Of 72 echocardiographie studies, 16 (22{\%}) showed valvular abnormalities. Cerebral angiography detected intracranial lesions in 24 of 49 patients (49{\%}). These data indicate that antiphospholipid antibodies can be identified in stroke patients without known autoimmune disorders. They also suggest that antiphospholipid antibody- associated cerebrovascular ischemia may be recurrent and often occurs in patients with systemic thromboembolic events. Our findings should help design a prospective clinical trial that will assess the risk of recurrent thromboembolism in this population, identify stroke risk factors, and address therapy.",
keywords = "Anticoagulants, anticardiolipin antibodies, Anticoagulants, antiphospholipid antibodies, Cerebrovascular disorders",
author = "{The Antiphospholipid Antibodies in Stroke Study Group} and Babikian, {Viken L.} and Brey, {Robin L.} and Coull, {Bruce M.} and Dewitt, {L. Dana} and Feinberg, {William M.} and Edward Feldmann and Richard Furie and Harris, {E. Nigel} and Hess, {David C} and Steven Kittner and Kushner, {Michael J.} and Levine, {Steven R.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1161/01.STR.21.9.1268",
language = "English (US)",
volume = "21",
pages = "1268--1273",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia

AU - The Antiphospholipid Antibodies in Stroke Study Group

AU - Babikian, Viken L.

AU - Brey, Robin L.

AU - Coull, Bruce M.

AU - Dewitt, L. Dana

AU - Feinberg, William M.

AU - Feldmann, Edward

AU - Furie, Richard

AU - Harris, E. Nigel

AU - Hess, David C

AU - Kittner, Steven

AU - Kushner, Michael J.

AU - Levine, Steven R.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - We reviewed the clinical and laboratory data of 128 patients with cerebrovascular disease and anti phospholipid antibodies. Cases were evenly divided between men and women, and the mean age of the study group was 46 years. Cerebral infarction occurred in 97 patients, and transient hemispheric ischemic attacks without stroke were recorded in 19; 12 suffered ocular ischemia. Systemic lupus erythematosus was diagnosed in 16% of all cases. Histories of systemic thromboembolic events and recurrent miscarriages were noted in 14% of the patients and in 19% of the women, respectively. Evidence of cerebral infarction preceding the index event was present in 30% of cases. During a mean follow-up of 16 months, nine of 96 (9%) patients sustained new cerebral infarctions. Of 72 echocardiographie studies, 16 (22%) showed valvular abnormalities. Cerebral angiography detected intracranial lesions in 24 of 49 patients (49%). These data indicate that antiphospholipid antibodies can be identified in stroke patients without known autoimmune disorders. They also suggest that antiphospholipid antibody- associated cerebrovascular ischemia may be recurrent and often occurs in patients with systemic thromboembolic events. Our findings should help design a prospective clinical trial that will assess the risk of recurrent thromboembolism in this population, identify stroke risk factors, and address therapy.

AB - We reviewed the clinical and laboratory data of 128 patients with cerebrovascular disease and anti phospholipid antibodies. Cases were evenly divided between men and women, and the mean age of the study group was 46 years. Cerebral infarction occurred in 97 patients, and transient hemispheric ischemic attacks without stroke were recorded in 19; 12 suffered ocular ischemia. Systemic lupus erythematosus was diagnosed in 16% of all cases. Histories of systemic thromboembolic events and recurrent miscarriages were noted in 14% of the patients and in 19% of the women, respectively. Evidence of cerebral infarction preceding the index event was present in 30% of cases. During a mean follow-up of 16 months, nine of 96 (9%) patients sustained new cerebral infarctions. Of 72 echocardiographie studies, 16 (22%) showed valvular abnormalities. Cerebral angiography detected intracranial lesions in 24 of 49 patients (49%). These data indicate that antiphospholipid antibodies can be identified in stroke patients without known autoimmune disorders. They also suggest that antiphospholipid antibody- associated cerebrovascular ischemia may be recurrent and often occurs in patients with systemic thromboembolic events. Our findings should help design a prospective clinical trial that will assess the risk of recurrent thromboembolism in this population, identify stroke risk factors, and address therapy.

KW - Anticoagulants, anticardiolipin antibodies

KW - Anticoagulants, antiphospholipid antibodies

KW - Cerebrovascular disorders

UR - http://www.scopus.com/inward/record.url?scp=0025171429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025171429&partnerID=8YFLogxK

U2 - 10.1161/01.STR.21.9.1268

DO - 10.1161/01.STR.21.9.1268

M3 - Article

VL - 21

SP - 1268

EP - 1273

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -